Drug Topics - October 13, 2008 - (Page 14) 14 DRUG TOPICS Oct. 13, 2008 www.drugtopics.com Letters Pharmacists must work together for change R egarding the article The Pharmacy Alliance in your Sept. 15 issue, I agree that organizations, both new and existing, need to focus on creating value around professional services over selling commodities (medications). Many issues are mentioned in the article, including the need to address unprofessional work environments, licensing, and reimbursement. I believe there are two primary issues that drive pharmacy practice in America, including a lack of reimbursement for professional pharmacy services, and antiquated laws governing pharmacy practice. Most states have not revised laws to allow pharmacists to spend more time on clinical activities. Additionally, the laws in most states provide no guidelines for clinically focused practice settings. As for work environments, nothing will change unless pharmacists begin billing for their services. Only when retailers see dollar signs attached to something other than dispensing medications will they make modifications. Connie Sullivan, RPh. National Director of Infusion Pharmacy Services If the FDA would like pharmacists to intervene, they must also give pharmacists some legality for clinical intervention. Sam Schiffman, RPh ctmsts@gmail.com Can’t buy me love I think PhRMA’s new marketing code is a total waste of time and effort. Does anyone really believe that health professionals would compromise their patients’ health and safety because of a gift of a pen or cup? I also think it’s foolish that politicians believe a pharmacist or cardiologist is going to cause harm to patients over a $50 meal at a steak house. David Bibeault, RPh, MBA Rhode Island dbibeault@lifespan.org Proper payment for services Pharmacists will never receive a fair dispensing fee no matter how many well-done studies reveal what we need to break even. As long as the big corporations are willing to undercut each other to increase their volume, dispensing fees will continue to be set low. We all know that many big corporations use the pharmacy department as a loss leader to get customers into their store to sell them a drill, 10 pounds of potatoes, or a new shirt. Pharmacists will never receive payment for patient counseling and medication therapy management because we are in the retail business. Pharmacists are not like lawyers and doctors who get paid for their legal and medical advice. They do not sell a product at retail. They sell advice, which is simply words, not made of matter, as are pills and liquids, and salves and creams. Roger O’Dell, RPh Sciotoville, Ohio Concerns about third class of drugs Drug Topics’ June 16 cover story “Has the Time Come for a Third Class of Drugs?” begs some additional questions. Putting pseudoephedrine behind the counter so that a pharmacist can monitor the sale of this drug to prevent its abuse brings up the issue of whether pharmacists have a clinical responsibility to ask the consumer if he/she has a heart or blood pressure condition. Most patients do not know their pressure. Do we take the patient’s word, or should we have the right to take the consumer’s blood pressure in the pharmacy or, if not, refuse the sale? Printed and e-mailed letters should be brief and include the writer’s name, address, daytime phone number, and date of the issue you are referencing: Editor, Drug Topics, 24950 Country Club Blvd., Suite 200, North Olmsted, OH 44070-5351. E-mail address: drugtopics@advanstar.com. Letters may be edited for length, style, and clarity at our discretion. http://www.drugtopics.com
Table of Contents Feed for the Digital Edition of Drug Topics - October 13, 2008 Drug Topics - October 13, 2008 Contents Latebreakers Letters Kansas Pharmacists Partner with Law Enforcement to Fight Meth Use Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics Rx Care JPat Large Celebrating Community Special Report Self-Care Government and Law Newer Treatment Option for Type 2 Diabetes New Products Advertisers Index Technology Classified Viewpoint:Pharmacists Must Change our Ways Drug Topics - October 13, 2008 Drug Topics - October 13, 2008 - (Page introA) Drug Topics - October 13, 2008 - (Page introB) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page Cover1) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page Cover2) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page 1) Drug Topics - October 13, 2008 - Contents (Page 2) Drug Topics - October 13, 2008 - Contents (Page 3) Drug Topics - October 13, 2008 - Contents (Page 4) Drug Topics - October 13, 2008 - Contents (Page 5) Drug Topics - October 13, 2008 - Contents (Page 6) Drug Topics - October 13, 2008 - Contents (Page 7) Drug Topics - October 13, 2008 - Latebreakers (Page 8) Drug Topics - October 13, 2008 - Latebreakers (Page 9) Drug Topics - October 13, 2008 - Latebreakers (Page 10) Drug Topics - October 13, 2008 - Latebreakers (Page 11) Drug Topics - October 13, 2008 - Latebreakers (Page 12) Drug Topics - October 13, 2008 - Latebreakers (Page HSE1) Drug Topics - October 13, 2008 - Latebreakers (Page HSE2) Drug Topics - October 13, 2008 - Latebreakers (Page HSE3) Drug Topics - October 13, 2008 - Latebreakers (Page HSE4) Drug Topics - October 13, 2008 - Latebreakers (Page HSE5) Drug Topics - October 13, 2008 - Latebreakers (Page HSE6) Drug Topics - October 13, 2008 - Latebreakers (Page HSE7) Drug Topics - October 13, 2008 - Latebreakers (Page HSE8) Drug Topics - October 13, 2008 - Latebreakers (Page HSE9) Drug Topics - October 13, 2008 - Latebreakers (Page HSE10) Drug Topics - October 13, 2008 - Latebreakers (Page HSE11) Drug Topics - October 13, 2008 - Latebreakers (Page HSE12) Drug Topics - October 13, 2008 - Latebreakers (Page HSE13) Drug Topics - October 13, 2008 - Latebreakers (Page HSE14) Drug Topics - October 13, 2008 - Latebreakers (Page HSE15) Drug Topics - October 13, 2008 - Latebreakers (Page HSE16) Drug Topics - October 13, 2008 - Latebreakers (Page HSE17) Drug Topics - October 13, 2008 - Latebreakers (Page HSE18) Drug Topics - October 13, 2008 - Latebreakers (Page HSE19) Drug Topics - October 13, 2008 - Latebreakers (Page 13) Drug Topics - October 13, 2008 - Letters (Page 14) Drug Topics - October 13, 2008 - Letters (Page 15) Drug Topics - October 13, 2008 - Letters (Page 16) Drug Topics - October 13, 2008 - Letters (Page 1s) Drug Topics - October 13, 2008 - Letters (Page 2s) Drug Topics - October 13, 2008 - Letters (Page 3s) Drug Topics - October 13, 2008 - Letters (Page 4s) Drug Topics - October 13, 2008 - Letters (Page 5s) Drug Topics - October 13, 2008 - Letters (Page 6s) Drug Topics - October 13, 2008 - Letters (Page 7s) Drug Topics - October 13, 2008 - Letters (Page 8s) Drug Topics - October 13, 2008 - Letters (Page 9s) Drug Topics - October 13, 2008 - Letters (Page 10s) Drug Topics - October 13, 2008 - Letters (Page 11s) Drug Topics - October 13, 2008 - Letters (Page 12s) Drug Topics - October 13, 2008 - Kansas Pharmacists Partner with Law Enforcement to Fight Meth Use (Page 17) Drug Topics - October 13, 2008 - Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics (Page 18) Drug Topics - October 13, 2008 - Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics (Page 19) Drug Topics - October 13, 2008 - Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics (Page 19a) Drug Topics - October 13, 2008 - Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics (Page 20) Drug Topics - October 13, 2008 - Rx Care (Page 21) Drug Topics - October 13, 2008 - Rx Care (Page 22) Drug Topics - October 13, 2008 - JPat Large (Page 23) Drug Topics - October 13, 2008 - Celebrating Community (Page 24) Drug Topics - October 13, 2008 - Celebrating Community (Page 25) Drug Topics - October 13, 2008 - Celebrating Community (Page 26) Drug Topics - October 13, 2008 - Celebrating Community (Page 27) Drug Topics - October 13, 2008 - Celebrating Community (Page 28) Drug Topics - October 13, 2008 - Celebrating Community (Page 29) Drug Topics - October 13, 2008 - Celebrating Community (Page 30) Drug Topics - October 13, 2008 - Celebrating Community (Page 31) Drug Topics - October 13, 2008 - Special Report (Page 32) Drug Topics - October 13, 2008 - Special Report (Page 33) Drug Topics - October 13, 2008 - Special Report (Page 34) Drug Topics - October 13, 2008 - Special Report (Page 35) Drug Topics - October 13, 2008 - Special Report (Page 36) Drug Topics - October 13, 2008 - Special Report (Page 37) Drug Topics - October 13, 2008 - Special Report (Page 38) Drug Topics - October 13, 2008 - Special Report (Page 39) Drug Topics - October 13, 2008 - Special Report (Page 40) Drug Topics - October 13, 2008 - Special Report (Page 41) Drug Topics - October 13, 2008 - Special Report (Page 42) Drug Topics - October 13, 2008 - Special Report (Page 43) Drug Topics - October 13, 2008 - Special Report (Page 44) Drug Topics - October 13, 2008 - Special Report (Page 45) Drug Topics - October 13, 2008 - Self-Care (Page 46) Drug Topics - October 13, 2008 - Self-Care (Page 47) Drug Topics - October 13, 2008 - Self-Care (Page 48) Drug Topics - October 13, 2008 - Self-Care (Page CP1) Drug Topics - October 13, 2008 - Self-Care (Page CP2) Drug Topics - October 13, 2008 - Self-Care (Page CP3) Drug Topics - October 13, 2008 - Self-Care (Page CP4) Drug Topics - October 13, 2008 - Self-Care (Page CP5) Drug Topics - October 13, 2008 - Self-Care (Page CP6) Drug Topics - October 13, 2008 - Self-Care (Page 49) Drug Topics - October 13, 2008 - Self-Care (Page 50) Drug Topics - October 13, 2008 - Self-Care (Page 51) Drug Topics - October 13, 2008 - Government and Law (Page 52) Drug Topics - October 13, 2008 - Government and Law (Page 53) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 54) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 55) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 56) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 57) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 58) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 59) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 60) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 61) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 62) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 63) Drug Topics - October 13, 2008 - Advertisers Index (Page 64) Drug Topics - October 13, 2008 - Advertisers Index (Page 65) Drug Topics - October 13, 2008 - Advertisers Index (Page 65a) Drug Topics - October 13, 2008 - Advertisers Index (Page 65b) Drug Topics - October 13, 2008 - Advertisers Index (Page 66) Drug Topics - October 13, 2008 - Advertisers Index (Page 67) Drug Topics - October 13, 2008 - Advertisers Index (Page 68) Drug Topics - October 13, 2008 - Advertisers Index (Page 69) Drug Topics - October 13, 2008 - Technology (Page 70) Drug Topics - October 13, 2008 - Technology (Page 71) Drug Topics - October 13, 2008 - Classified (Page 72) Drug Topics - October 13, 2008 - Classified (Page 73) Drug Topics - October 13, 2008 - Classified (Page 74) Drug Topics - October 13, 2008 - Classified (Page 75) Drug Topics - October 13, 2008 - Viewpoint:Pharmacists Must Change our Ways (Page 76) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page Cover1) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page Cover2)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.